This year, the ninth annual WuXi Global Forum premiered virtually and concurrently during the J.P. Morgan Healthcare Conference week. With the theme of “Advancing Breakthroughs for Patients,” this year’s Forum […]
SHANGHAI, December 2, 2020 — WuXi AppTec, a leading global provider of R&D and manufacturing enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has […]
Can we build a roadmap to conquer Multiple Sclerosis (MS), a disease that impacts more than 2 million globally as the leading non-traumatic disability disorder in young adults?
August is the month each year when special efforts are made to raise awareness of patients suffering from Spinal Muscular Atrophy (SMA), a crippling, degenerative neuromuscular disease. In its most severe form, SMA is the leading genetic cause of infant death. WuXi AppTec welcomes the opportunity to contribute to SMA Awareness Month this year..
This complimentary webinar will convene leading physicians, drug developers, patients and advocates. These experts will discuss the latest advances in the development of transformative medicines for hemophilia, including gene therapy and next generation technologies.
In honor of World Neurofibromatosis (NF) Awareness Month, the WuXi AppTec community is proud to join the millions around the world working to enhance our understanding of this rare disease.
WuXi AppTec hosted the second online forum on the COVID-19 pandemic, titled “Harnessing Our Collective Power”, which attracted 2487 viewers via Zoom and 112,000 viewers via live streaming from 37 countries and regions.